Breakthrough Cancer Therapy Moves to Phase 2 Trials (IMAGE)

Georgia State University

Breakthrough Cancer Therapy Moves to Phase 2 Trials

Caption

“It’s deeply rewarding to see DZ-002 advance into Phase 2 trials, marking a promising step forward in cancer treatment and offering hope for improved patient outcomes,” says Professor of Chemistry Maged Henary, associate chair of the Department of Chemistry at Georgia State.

Credit

Courtesy: Georgia State University

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.